Magseed®-guided long-term marking of target lymph nodes in neoadjuvant therapy of early breast cancer patients - experiences in 13 patients

T Schnitzbauer,F Khandan,M Thill

Senologie - Zeitschrift für Mammadiagnostik und -therapieWissenschaftliche Abstracts zur 40. Jahrestagung der Deutschen Gesellschaft für Senologie e.V. (DGS) Interdisziplinär. Kommunikativ. Digital（2021）

Cited 0|Views0

No score

Abstract

Aim Neoadjuvant systemic therapy (NAST) and targeted axillary dissection (TAD) aim de-escalation of surgical radicality while guaranteeing oncological safety. Therefore, reliable marking of target lymph nodes (TLN) is mandatory. Available clips come along with challenges including migration and unsatisfactory detection rates. Magseed® magnetic marker is designed to overcome these issues and CE-certified for long-term marking of soft tissue. First US-data are promising. We report our experiences with Magseed® TLN biopsy.

Translated text

Key words

early breast cancer patients,target lymph nodes,breast cancer,neoadjuvant therapy,lymph nodes,long-term

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined